
The largest academic research spender in the United States, producing a steady stream of biotech and medical device ventures.
Johns Hopkins University consistently leads American universities in total research expenditure, driven by its medical school, public health school, and Applied Physics Laboratory.
Its venture output follows that research base almost exactly: therapeutics, diagnostics, medical devices, and health data companies.
FastForward provides incubator space and support for Hopkins-affiliated ventures, with dedicated laboratory facilities for companies that need them. The Pava Center coordinates student entrepreneurship across schools.
Baltimore's cost base is low relative to the Boston and Bay Area biotech clusters, and proximity to Washington gives regulatory and federal funding access.
Hopkins spinouts are overwhelmingly in life sciences — therapeutics, diagnostics, surgical devices, and health information systems — reflecting the university's research concentration. Volume in software and consumer is comparatively low by design.
The Baltimore-Washington corridor includes Blu Venture Investors and TEDCO, Maryland's state-backed early investor, with substantial federal grant funding available through NIH and related programmes given the region's proximity to Washington.
GCN’s global network includes millions of startups and founders and a broad community of investors, creating opportunities to discover potential connections across university communities.
.png)




